Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas

Leukemia and Lymphoma

Volumn 55, Issue 4, 2014, Pages 957-958

  Marstrand, Troels ^a   Ahler, Charlotte B ^a,b   Ralfkiaer, Ulrik ^b,c   Clemmensen, Anders ^d   Kopp, Katharina L ^b   Sibbesen, Nina A ^b   Krejsgaard, Thorbjørn ^b   Litman, Thomas ^a   Wasik, Mariusz A ^e   Bonefeld, Charlotte M ^b   Grønbæk, Kirsten ^c   Gjerdum, Lise Mette Rahbek ^c   Gniadecki, Robert ^f   Ralfkiaer, Elisabeth ^c   Geisler, Carsten ^b   Woetmann, Anders ^b   Røpke, Mads A ^a   Glue, Christian ^b   Skov, Lone ^d   Odum, Niels ^b  

^a LEO PHARMA A S   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c Rigshospitalet   (Denmark)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ATOPIC DERMATITIS; CUTANEOUS T CELL LYMPHOMA; DIAGNOSTIC ACCURACY; ECZEMA; HUMAN; LARGE CELL LYMPHOMA; LETTER; MYCOSIS FUNGOIDES; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY; GENE EXPRESSION PROFILING; GENETICS; LYMPHOMA, T-CELL, CUTANEOUS; REPRODUCIBILITY; SKIN NEOPLASMS;

GENE EXPRESSION PROFILING; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SKIN NEOPLASMS;

EID: 84904277764     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2013.815352     Document Type: Letter

References (12)

1. PimpinelliN, OlsenEA, SantucciM, et al.;International Society for Cutaneous Lymphoma. Defining early mycosis fungoides. J Am Acad Dermatol 2005;53:1053-1063.
2. Shin J, Monti S, Aires DJ, et al. Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome. Blood 2007;110:3015-3027. (Pubitemid 350006956)
3. Wong HK, Mishra A, Hake T, et al. Evolving insights on the pathogenesis and therapy of cutaneous T-cell lymphoma. Br J Haematol 2011; 155: 150-166.
4. Garzon R, Marcucci G. Potential of microRNAs for cancer diagnostics, prognostication and therapy. Curr Opin Oncol 2012;24: 655-659.
5. Baer C, Claus R, Plass C. Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res 2012;73:473-477.
6. Fabbri M, Croce CM, Calin GA. MicroRNAs in the ontogeny of leukemias and lymphomas. Leuk Lymphoma 2009; 50: 160-170.
7. Ballabio E, Mitchell T, van Kester MS, et al. MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. Blood 2010; 116: 1105-1113.
8. Husby S, Geisler C, Grenbaek K. MicroRNAs in mantle cell lymphoma. Leuk Lymphoma 2013 Feb 19. [Epub ahead of print]
9. Ralfkiaer U, Hagedorn PH, Bangsgaard N, et al. Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL). Blood 2011;118:5891-5900.
10. Kopp KL, Ralfkiaer U, Gjerdrum LMR, et al. STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma. Cell Cycle 2013 May 15. [Epub ahead of print]
11. He J, Zhang F, Wu Y, et al. Prognostic role of microRNA-155 in various carcinomas: results from a meta-analysis. Dis Markers 2013 Mar 12. [Epub ahead of print]
12. Sonkoly E, Janson P, Majuri ML, et al. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J Allergy Clin Immunol 2010;126:581-589.e1-20.